Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)

HNX:DP3 Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 6, 2026	Dec 31, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1,363,096	1,135,196	1,253,446	1,408,246	808,400	971,800
Market Cap Growth	12.21%	-9.43%	-10.99%	74.20%	-16.81%	30.18%
Enterprise Value	921,840	736,739	929,277	1,160,824	640,122	859,776
Last Close Price	63400.00	52800.00	55479.03	59751.45	31646.29	36075.15
PE Ratio	8.88	7.39	10.34	11.24	7.43	10.31
PS Ratio	3.11	2.59	3.00	3.44	1.67	2.55
PB Ratio	2.24	1.87	2.42	3.01	1.94	2.65
P/TBV Ratio	2.32	1.93	2.51	3.14	1.97	2.70
P/FCF Ratio	-	4.69	13.86	9.60	9.61	37.58
P/OCF Ratio	5.63	4.69	13.64	9.20	8.15	36.94
EV/Sales Ratio	2.10	1.68	2.23	2.83	1.32	2.26
EV/EBITDA Ratio	5.06	4.05	6.21	7.69	-	-
EV/EBIT Ratio	5.41	4.32	6.80	8.48	5.01	7.67
EV/FCF Ratio	-	3.04	10.27	7.91	7.61	33.24
Debt / Equity Ratio	0.06	0.06	-	0.02	0.01	0.01
Debt / EBITDA Ratio	0.19	0.19	-	0.05	-	-
Debt / FCF Ratio	0.14	0.14	-	0.05	0.06	0.14
Asset Turnover	0.64	0.64	0.71	0.76	1.02	0.86
Inventory Turnover	2.99	2.99	2.94	2.10	2.17	1.90
Quick Ratio	3.55	3.55	4.29	3.25	2.60	2.31
Current Ratio	3.96	3.96	4.88	3.79	3.43	3.22
Return on Equity (ROE)	27.26%	27.26%	24.55%	28.28%	27.77%	26.46%
Return on Assets (ROA)	15.62%	15.62%	14.50%	15.87%	16.76%	15.81%
Return on Invested Capital (ROIC)	90.02%	71.80%	62.83%	56.58%	48.04%	44.85%
Return on Capital Employed (ROCE)	28.00%	28.00%	26.30%	29.20%	30.60%	30.60%
Earnings Yield	11.27%	13.53%	9.67%	8.89%	13.46%	9.70%
FCF Yield	-	21.32%	7.22%	10.42%	10.41%	2.66%
Dividend Yield	4.93%	-	-	5.02%	-	6.65%
Payout Ratio	40.50%	40.50%	53.22%	54.84%	45.84%	70.55%
Buyback Yield / Dilution	-	-	-	5.00%	-5.27%	0.00%
Total Shareholder Return	4.93%	-	-	10.02%	-5.27%	6.65%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.